ArticleThe Journal of dermatological treatment2022
A qualitative study of dermatology patients and providers to understand discordant perceptions of symptom burden and disease severity.
Article in The Journal of dermatological treatment, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Electronic patient-reported outcome measures for triaging and scheduling outpatient appointments: a systematic review and meta-analysis.Journal of the American Medical Informatics Association : JAMIA · 2025Pooled it
- Economic Evaluation of a Digital Psychobehavioral Intervention for Chronic Inflammatory Skin Disease (MindMySkin): Protocol for a Trial-Based Cost-Effectiveness Analysis.JMIR research protocols · 2026Article
- Patient Experience and Preferences for Treatments in Atopic Dermatitis.Dermatology and therapy · 2026Article
- Early Response to Calcipotriol and Betamethasone Dipropionate PAD-Cream at Week 4 in Patients with Mild-to-Moderate Plaque Psoriasis: A Post-Hoc Pooled Analysis of Two Phase III Trials.Dermatology and therapy · 2026Article
- The brain-skin connection: A narrative review of neuroendocrine and immune pathways.JAAD international · 2026Article
- Digital psychotherapeutic interventions to reduce dermatological symptom burden: Development and testing of MindMySkin.JAAD international · 2026Article
- Article
- Impact of disease cyclicity on quality-of-life impairment-A mixed method explanatory study.JAAD international · 2025Article
- What makes a challenging consult: A cross-sectional study of 1053 dermatology patients in Singapore.JAAD international · 2023Article
- The psychosocial burden of hidradenitis suppurativa in Singapore.JAAD international · 2023Article
- Qualitative analysis of topical corticosteroid concerns, topical steroid addiction and withdrawal in dermatological patients.BMJ open · 2022Article
Corrections and comments
- Commented on by
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPatients often present with symptoms that are disproportionate to the observed disease state, and grade disease severity differently from healthcare providers (HPs). This discordant symptom burden and severity grading (DSG) results in poorer patient care. Current research on DSG is limited, relying on structured models that are theoretically incomplete.
objectiveTo fully understand the factors driving DSG.
methodsQualitative study of dermatology patients and HPs. Interview data were analyzed using grounded theory to derive a model of the causes of DSG.
resultsEighteen patients and 12 HPs were interviewed. Results reflect a tendency for patients to grade their conditions more severely than HPs. Factors driving DSG are related to emotional and cognitive disparities in the constructs used to grade severity, varying consequences of disease due to differing resilience and coping methods, socio-psychological factors influencing how patients report their symptoms, and the context of the consult.
conclusionA better understanding of DSG is required for achieving mutual understanding and patient-centered collaborative care. It is easy to label a patient with high symptom burden as having a low threshold for discomfort, or for a patient to presume that the doctor is unempathetic. This study suggests the causes of DSG are nuanced and multifactorial.
Indexed as
Identifiers
34314298What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.